Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. Innovation

Innovation

4 things scientists now know about autoimmune diseases in kids

Two experts in the field share the latest understanding and research into conditions like pediatric plaque psoriasis, juvenile idiopathic arthritis and pediatric active psoriatic arthritis—diseases that afflict children and can have long-term damaging effects into adulthood if not properly treated.

Johnson & Johnson Chairman and CEO appears at the White House to discuss the company’s collaboration with Merck and future vaccine production

Learn more about the event, Johnson & Johnson’s historic collaboration with Merck—and watch a video that chronicles the progress that the company has made since last March in the fight against COVID-19.

4 things we now know about the rare disease AL amyloidosis

Imagine having a disease that many doctors have never seen before. That’s what Marty Verel experienced when he was told he had AL amyloidosis—and it’s what hematologist Brendan Weiss, M.D., is determined to help change. For Rare Disease Day, Dr. Weiss shares what he’s learned studying the rare disease.

A message from Chairman and CEO Alex Gorsky about the Emergency Use Authorization of Johnson & Johnson’s Janssen COVID-19 vaccine

The company leader shares the latest news about the U.S. Food and Drug Administration’s decision about the single-shot Janssen COVID-19 vaccine.

“COVID-19 inspired me to improve patient care": How two nurses devised new ways to help kids and fellow nurses during the pandemic

From a virtual reality game that helps children with remote physical therapy to a clever way to upgrade personal protective equipment for healthcare workers, the winning ideas from the latest Johnson & Johnson Nurses Innovate QuickFire Challenge came out of medical conundrums posed by the pandemic. Meet the women behind them.

4 ways Johnson & Johnson has worked to make access to medicines around the world more equitable

The Access to Medicine Index, a ranking of pharmaceutical companies’ work to distribute medications to low- and middle-income countries, just named Johnson & Johnson #3 on its biennial list, underscoring the company’s deep history of ensuring people in underserved communities receive the treatments they need.

3 ways Johnson & Johnson is innovating to help fight tuberculosis

It’s one of the world’s deadliest infectious diseases, killing more people each year than HIV/AIDS and malaria combined. We’re taking a look back at the strides the company has made in fighting this preventable illness to help bring us closer to a tuberculosis-free world.

Impact during a pandemic: 5 ways Johnson & Johnson was recognized for its COVID-19 work in 2020

From Fast Company‘s 2020 Best Workplaces for Innovators to Interbrand‘s Best Global Brands of 2020, learn about some of the distinctions that the company has been honored with this year for its work to help people and communities around the world.

“I’m a nurse who’s also a healthcare entrepreneur": Meet the woman behind an app designed to help nurses battle burnout

Treating patients day and night is just one part of the job description for this enterprising nurse, who has made it her mission to help fellow nurses persevere during the pandemic and beyond. And it’s not her first great healthcare innovation.

At the heart of science: How a small chewable tablet is helping tackle a disease that impacts nearly 1 billion children globally

Imagine getting so sick from a preventable disease that you can’t play or attend school—multiple times a year. For World Children’s Day, we’re sharing the story of Sheti and others just like her who now have a chance to take back their childhoods, thanks to a new formulation of a medication to treat intestinal worms.